[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539563":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":37,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Clara Vigneron, MD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","06 33 14 56 50","clara.vigneron@aphp.fr",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Romain Sonneville, MD, PhD","01 40 25 61 39","romain.sonneville@aphp.fr",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":26,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Cochin hospital","RECRUITING","Paris","France","75014","FR",{"type":30,"coordinates":31},"Point",[32,33],2.3488,48.85341,{"lat":33,"lon":32},[36],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100539563","prognosis-of-disseminated-and-cerebral-toxoplasmosis-hospitalized-in-intensive-care-in-the-era-of-pcr-diagnosis-100539563",false,"NCT06305468","Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis","Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis - Toxoplasmosis in ICU (TOXIC)","TOXIC","Inclusion Criteria:\n\n* Adult patient hospitalized in intensive care\n* At least 1 organ failure (SOFA\\> or =2)\n* PCR toxoplasmosis on CSF, blood, BAL, or bone marrow positive within 7 days before or after admission to ICU\n\nExclusion Criteria:\n\n* Post-mortem diagnosis\n* Primary outcome not available\n* Patient living informed and not opposed to the reuse of their data in this research.","ALL","18 Years","100 Years",{"count":51,"type":52},200,"ESTIMATED","OBSERVATIONAL","Toxoplasmosis is a common infection whose clinical severity can sometimes justify admission to intensive care, especially in immunocompromised patients.\n\nThis study should make it possible to evaluate the impact of different anti-infective treatment regimens and to highlight clinical-biological and prognostic differences depending on the type of underlying immunosuppression.",[56],"Toxoplasmosis",[58],"toxoplasmosis","2025-01-24",{"date":61,"type":62},"2025-01-28","ACTUAL",{"date":64,"type":62},"2024-08-01",{"date":66,"type":52},"2026-04-01",{"name":5,"class":6},1]